 MELBOURNE, Australia, Aug. 16, 2022 GLOBE NEWSWIRE -- Opthea Limited ASX:OPT; NASDAQ:OPT, a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced that Chief Executive Officer Dr. Megan Baldwin will present at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference, taking place virtually on August 17, 2022. 